Skip to content
lifestyle.emphas.is
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Adlai Nortye Group Ltd.
Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab
October 15, 2026
Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations
September 30, 2026
Adlai Nortye’s AN4035 ADC Dosed First Patient, FDA IND Cleared
September 8, 2026